Streamline your business deal for Life Sciences with airSlate SignNow

How to create outlook signature

Carl Berg is an amazing story of self-made success a vending machine repairman who paid his own way through college he turned his real estate investments into a highly coveted portfolio he sold for more than a billion dollars now he's in the Venture Capital game investing in Tech and the life science Industry a topic that is a real passion for me joining me now in a CBC exclusive is Carl ber Carl good to have you on the program thank you thanks so much for joining us so almost a year ago you sold your real estate portfolio for 1.3 billion now you run Bur Berg and are backing a number of interesting technology companies why did you cut your exposure to real estate as much as you did well I'd been in the business for 45 years and just felt it was a good time to get out during that entire time I've been in Venture Capital my first real estate deal was actually a venture capital deal where we invested in the company that took least our building and so I've been doing that for 45 years where is seeing the uh opportunity in uh in in Venture Capital right now I know you're active in life sciences how big is the opportunity what are you seeing I think it's absolutely huge the company that we have Berg is basically has the opportunity to revolutionize healthc care yeah I I I love this idea I've been looking at you know the idea of sensors very closely you know inserting a sensor into your bloodstream and then it'll alert you to when you're going to have a heart attack and tell you to go to the doctor or you know taking pictures of a skin disease in India and having the best doctors all around the world look at it because of the technology so what what specific areas do you find most exciting in terms of where the growth is right now in life sciences well it's the approach we're taking on this is we're using biology to determine the differences between a healthy person and a person that has a disease then we're taking all of that data and we exclude no data whatsoever and we're taking all of that data and running it through supercomputers and with that process and the patented process we use we're able to come up with biomarkers and Drug targets and if we're successful and at all indications are we will be we'll be able to revolutionize the drug industry and the other thing that we do we work only with uh proteins that exist in the body so this eliminates most if not all of the side effects and toxicity so see if what we're doing works it just changes everything well I mean it sounds like a similar opportunity is 23 and me um of course started by an wuis uh where you know you can spit into a tube and then they can extract the DNA and and tell you various diseases that you're susceptible to is that is that similar to what you're talking about not really it's it's kind of an approach a slightly different approach we're actually primarily looking for drug drug targets and biomarkers that can determine the disease and for example our first our first drug is a cancer drug that's now being tested at D Anderson and Cornell in New York City and we're going to start later this week in paloalto Medical Foundation that's terrific I it sounds so Innovative um let me ask you you you were one of the First Investors in Sun micro um that was a that was a big hit for you integrated devices technology another one of your companies what's your take on the evolvement of the technology space in terms of cloud computing the Boom in some of these uh retail areas like smartphones and tablets social media do you think there's a bigger growth potential in life sciences as it relates to technology as a as opposed to some of these other areas of check that we're zeroing in on so much like the cloud well I think the life sciences are going to take advantage of all these new things that are happening the technology Market is going to radically change over the next two or three years we're going to see a whole new generation of technology in the technology Market also but fun fundamentally uh biotech is going to take advantage of this and that's what our company does we do 41 trillion transactions on a supercomputer and then we get a results and one of the things that's really amazing that we're able to do we get a result that looks like a PC board and then we're over able to Overlay cancer diabetes heart disease and obesity on top of of each other and understand the connections between each one of these diseases yeah which is why we see Watson working so closely with folks like Cleveland Clinic and you know Watson working alongside healthc care companies uh supercomputer really is able to digest information and data so much faster than humans no with some of the technology that'll be coming out the next year or two when we first started using our platform it was taking us up a month or so to get all of the data back from the from the the computer operator right now we're doing that in a day or two and in the near future we'll probably be able to do that in hours Great Stuff Carl good to have you on the program thanks very much thank you we'll see you soon we appreciate your time tonight A Washington Scandal or a misleading headline the New York Post reporting that the